Discovery: Leverage Intelligence
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
Why 2026 Brand Planning Needs to Include Intelligence
Sign Up to Stay Ahead of Message Impact
Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.
Inside This Session
This quick 3 min clip to show how Talking Medicines Advanced Data Science and AI supports sharper strategy, clearer HCP intelligence, and measurable campaign impact for Brand Planning in 2026. Ready to power your 2026 strategy with real health intelligence? Let’s talk.
More from The Talking Room
Large Language Models and Regulatory-Grade GLP-1 Content: Challenges and the Need for Accurate Message Measurement
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.
Introducing DrugVoice
DrugVoice turns unstructured HCP data into Predictive HCP Intelligence, revealing how scientific messaging lands and influences HCP behavior.